Access assistance and MTM protocols key to successfully curing hepatitis C in co-infected patients. May 2, 2016 - Atlanta, Georgia - For a cohort of hepatitis C and HIV co-infected patients, Curant Health reports that its C The Cure program produces sustained virological response (SVR12) in 89.7% of program patients at 12 weeks post treatment. […]